How to start a longevity clinic, a complete founder’s guide

July 29, 2026

TL;DR

Starting a longevity clinic in 2026 is no longer a niche bet. There is demand, the clinical playbook is increasingly clear, and the hard questions have moved from what services to offer to how to deliver continuous, evidence-based care at scale.

The clinical foundation is the 4P framework (Predictive, Preventive, Personalized, Participatory), the operating model that separates a longevity clinic from a med-spa or TRT shop.
Choose the delivery model deliberately. Cash-based concierge, telehealth, or hybrid each trade off depth, scalability, and economics differently.
The diagnostic baseline matters. A genome, comprehensive biomarker panel, functional measures (VO2 max, grip strength, DEXA), and biological age testing form the modern starting point.
The harder problem is workflow architecture, the systems that turn continuous data into continuous care without burning out the clinician.
Year-one decisions compound. The operating system chosen in year one determines what can scale by year three.

Why 2026 is the moment to start a longevity clinic

At the most recent Roundtable of Longevity Clinics, Reya.ai presented preliminary data from a global survey of longevity clinic operators. Roughly 75 percent of the clinics surveyed said they were either unhappy with their practice management software or felt it needed substantial further development (Samir Mitra, Longevity.Technology interview, February 2025).

That pattern matters because it points at the harder question lurking under the easier one. Founders ask how to start a longevity clinic. The clinics already running say the gap is operational, meaning workflow, software, continuous engagement, and behavior change at scale.

This guide covers both. It works through the clinical foundation, the business model, the diagnostic baseline, the staffing model, the tech stack, the compliance landscape, the economics, and the workflow architecture that determines whether the clinic still works in year three.

What a longevity clinic actually is, and what it is not

A longevity clinic is structurally different from the practices it gets confused with.

It is not a med-spa, because med-spas focus on aesthetic procedures rather than clinical preventive care.
It is not a TRT or peptide clinic, because single-modality clinics deliver one intervention class, not multi-pillar care.
Not a functional medicine practice, though it borrows from one, because functional medicine is systems-based but often disease-treatment-oriented rather than healthspan-oriented.
And it is not a primary care practice, because primary care is built around acute and chronic disease management with reimbursement-driven workflow.

What defines it instead is a clinical practice built around the 4P framework (Predictive, Preventive, Personalized, Participatory) applied to extending healthspan. The patient is not sick. The time horizon is multi-year. The intervention spans biomarkers, lifestyle, behavior change, and clinical protocols across cardiovascular, metabolic, cognitive, musculoskeletal, and hormonal pillars concurrently.

The historical foundation matters here, because it is what separates a serious practice from a rebrand. Hood and Galas’s 2008 P4 medicine white paper formalized the framework, and Sagner et al.’s 2017 “The P4 Health Spectrum” paper explicitly applied it to chronic disease and healthspan. Longevity medicine is, structurally, P4 medicine in clinical practice. This is the framework everything else in the clinic should be built around.

For a deeper treatment of the 4P framework and its peer-reviewed foundations, see Reya’s article on the 4 Ps of medicine.

The “longevity clinic” label is becoming overloaded, since med-spas, TRT clinics, IV-drip shops, and serious longevity practices all use it. As a result, the label tells the prospective member less than the operating framework does.

“Longevity clinics need software that supports personalized, preventive, predictive and participatory (4P) care in order to deliver meaningful results to their customers. This contrasts with software designed for sick-care, which is episodic, reactive, and notes-focussed to drive billing.”
— Samir Mitra, Founder and CEO of Reya.ai. Longevity.Technology interview, February 2025.

Choose your delivery model deliberately

Three delivery models dominate current practice, and each carries different operational trade-offs. The table below summarizes them before the detail.

Delivery model	Clinical depth	Speed to launch	Capital cost	Scalability	Churn risk	Best fit
Cash-based concierge (in-person flagship)	Highest	Slowest (months)	High: build-out plus DEXA, VO2 max, CGM stations, sometimes whole-body MRI	Geographically limited	Lowest	Depth and margin over volume
Telehealth-first	Lower	Fastest (weeks)	Low	National immediately	Higher	Single-modality offers (peptides, hormone therapy)
Hybrid	High	Hardest to execute well in year one	Medium to high	Strong	Medium	Full 4P care at scale, the converging model

Cash-based concierge with an in-person flagship gives the highest clinical depth and the highest per-member touch, and its unit economics are strongest on a per-member basis. Build-out cost is significant, because high-end design, diagnostic equipment, and physical space are real capital costs. Geographic reach is limited, and the model requires a full-time multidisciplinary clinical team on-site. The trade-off is depth and margin at the cost of volume.

Telehealth-first launches faster and cheaper, in weeks rather than months, with national scalability immediately. The trade-offs are real, though. Diagnostics infrastructure is harder to deliver without a physical footprint, patient-clinician rapport builds more slowly, and member churn often runs higher. As a result, the model fits single-modality offerings such as peptide therapy or hormone replacement better than full P4 protocols.

The hybrid model combines telehealth scalability with in-person depth for diagnostics and high-touch interventions. It addresses the trade-off honestly, which is why it is the model most successful new longevity practices are converging on. However, it is also the hardest to execute in year one, because managing two channels and ensuring continuous care across them requires workflow architecture that the single-channel models can paper over for a while.

The deeper question across all three models is not which model to pick. It is how to deliver continuous engagement across the model. That is the workflow question, and it is covered in the workflow section below.

From Reya’s customer base, the hybrid model is increasingly the modal choice but also the hardest to execute well in year one. Telehealth-first clinics frequently add an in-person tier later and underestimate the workflow cost of doing so. Because membership economics depend on retention, and retention depends on the workflow holding together across channels, the channel decision is really a workflow decision in disguise.

The diagnostic baseline a longevity clinic needs

The diagnostic baseline a longevity practice needs in 2026 spans imaging, biomarkers, aging-specific tests, and functional measures. The table maps the categories, and the detail follows.

Category	Core tests	What it establishes
Imaging and body composition	DEXA, VO2 max via CPET, whole-body MRI (advanced), heart rate variability	Body composition, visceral fat, bone density, cardiorespiratory fitness, autonomic status
Biomarker panel	ApoB, Lp(a), hsCRP, NT-proBNP; HbA1c, fasting insulin, HOMA-IR; GGT, cystatin C, eGFR; hormones; vitamin D, omega-3 index	Cardiovascular, metabolic, liver and kidney, hormonal, and micronutrient status
Aging-specific testing	Epigenetic clocks (DunedinPACE, GrimAge), Systems Age framework, genome sequencing, microbiome assessment	Pace of aging, mortality risk, pharmacogenomics, disease predisposition, gut diversity
Functional measures	Grip strength, gait speed, balance testing, baseline neurocognitive assessment	Functional reserve and early indicators of decline

Imaging and body composition starts with a DEXA scan for body composition, visceral adipose tissue, and bone density. VO2 max via cardiopulmonary exercise testing is the single strongest predictor of all-cause mortality (Mandsager et al. 2018, JAMA Network Open). Whole-body MRI supports early lesion detection in advanced offerings, and heart rate variability serves as an autonomic nervous system marker.

The biomarker panel covers cardiovascular markers (ApoB for atherogenic particle count, Lp(a) for genetic risk, hsCRP for inflammation, NT-proBNP for cardiac stress), metabolic markers (HbA1c, fasting insulin, and HOMA-IR, the index that catches dysglycemia years before fasting glucose rises), liver and kidney function (GGT, cystatin C, eGFR), hormones (testosterone, estradiol and progesterone, DHEA-S, thyroid panel, cortisol rhythm), and others such as vitamin D, omega-3 index, and lipid subfractions.

Aging-specific testing adds biological age through epigenetic clocks, with DunedinPACE for pace-of-aging tracking and GrimAge for mortality prediction. The 2025 Systems Age framework (Sehgal and Levine, Nature Aging) adds a multi-system profile as it becomes commercially available. Genome sequencing supports pharmacogenomics and disease predisposition (APOE for dementia risk, BRCA for cancer risk, familial hypercholesterolemia variants), and microbiome assessment covers gut microbial diversity.

Functional measures round out the baseline. Grip strength, which the 2015 Leong PURE study established as a powerful mortality predictor (Lancet 2015), joins gait speed, balance testing, and a baseline neurocognitive assessment as early indicators of functional decline.

For a deeper treatment of biological age testing methods, see Reya’s piece on what biological age is and how it is actually measured.

In Reya’s customer base, the diagnostic baseline is often where new clinics either overspend, buying every imaging modality and every biomarker, or underspend and stop at the basics. The right baseline is comprehensive but not exhaustive, meaning enough to establish meaningful trajectories for the protocols the clinic actually offers.

“We (and our care teams) are drowning in a flood of health data from biomarkers, diagnostics, wearables, and lifestyle metrics without a system that can make sense of it all in real time.”

— Samir Mitra, Founder and CEO of Reya.ai. LinkedIn, 2025.

Building the workflow that makes all of this work. Coordinating advanced diagnostics, biomarker tracking, behavior-change protocols, and continuous engagement across hundreds of members is a workflow problem before it is a clinical one.

Reya sits on top of the EMR your clinic already runs, as a longevity-intelligence layer rather than a replacement for it. It reads the fragmented data from the EMR, labs, and wearables and turns it into one continuous Northstar view, so member intake, biomarker trends, lifestyle data, clinical protocols, and follow-up cadence live in one place. Correlation AI surfaces the signals that matter, and the Daily Health Assessment Agent flags risk around the clock, without adding clinician hours.

Book a demo

Building your clinical protocols around the pillars

Most working longevity clinics organize protocols around clinical pillars rather than around treatment modalities.

Metabolic health protocols are built around insulin sensitivity, glycemic control, and lipid management, where the first-line interventions are dietary architecture, sleep optimization, and resistance training. Pharmacotherapy follows when lifestyle intervention is not sufficient.

Cardiovascular health centers on ApoB-targeting protocols, Lp(a) management, and hypertension control. AHA and USPSTF guidelines remain the foundation, though longevity practice adjusts targets more aggressively than primary care typically does.

Cognitive health uses APOE-aware protocols for at-risk members, particularly APOE4 carriers, combined with inflammation management, sleep optimization, and cognitive training. Hearing testing and management are increasingly recognized as critical for dementia-risk reduction.

Musculoskeletal integrity covers sarcopenia prevention, bone density maintenance, and fall-risk reduction in older members. Resistance training is non-negotiable here, because it is the single most underprescribed longevity intervention.

Hormonal optimization spans testosterone, estradiol and progesterone, thyroid, and cortisol rhythm. It is the most controversial pillar, so protocols must be evidence-led and risk-managed. The reputational risk for the practice is real if hormones are handled poorly.

Each pillar has its own diagnostic baseline, first-line interventions, monitoring cadence, and escalation pathway. A longevity clinic delivers all five concurrently for each member, with the prioritization adjusted to individual risk and goals. From operator experience, the pillar approach is what allows protocols to scale across members without becoming generic, because the framework stays consistent while the application stays personalized.

The workflow architecture problem where most clinics break

This is the section that earns the article, because clinical content is well-documented while workflow architecture is where most new longevity clinics fail.

A longevity clinic’s value comes from continuous engagement and continuous data integration, not from episodic appointments. Members are not sick, so the win is detecting drift before symptoms appear and intervening early. That requires a workflow that captures continuous data (wearables, lifestyle, symptoms, periodic biomarkers), synthesizes it across pillars so metabolic, cardiovascular, cognitive, and hormonal data are not living in separate silos, surfaces actionable insights to the care team without flooding them, translates insights into protocol adjustments, and reinforces behavior change through coaching and accountability between visits.

This is what most clinics get wrong in year one. Not the clinical content, but the workflow. Members fall off engagement within six to eight weeks, data accumulates without being acted on, and coaches deliver generic plans rather than personalized adjustments. As a result, the clinic ends up delivering quarterly snapshots rather than continuous care.

It matters economically because membership renewal depends on perceived value, and perceived value depends on measured outcomes and sustained engagement. Workflow architecture is therefore the upstream variable that determines both. This is the operational reality the 2025 Demaria editorial in Aging-US flagged: many longevity clinics fail to deliver on the proactive-care promise not because the science is wrong but because the operational infrastructure is missing.

For founder-stage operators, the workflow architecture decision is the single most consequential choice in year one, because the operating system the clinic is built on either compounds its capabilities over time or constrains them.

“Proactive care requires continuous engagement. Continuous insight requires continuous data. And continuous data requires AI to manage and process.”
— Samir Mitra, Founder and CEO of Reya.ai. LinkedIn, 2025.

In Reya’s customer base, clinics that solve continuous engagement maintain materially higher annual retention than clinics that do not, and that retention differential compounds into year-three economics.

Staffing the team that actually delivers

The multidisciplinary team that defines a working longevity clinic typically includes seven roles, summarized below.

Role	What they own	Year-one necessity
Medical director / lead physician	Clinical vision, protocol oversight, care-plan sign-off	Essential
Nurse practitioner or physician assistant	Member follow-ups, protocol implementation, daily clinical ops	Essential
Health coach	Behavior change, adherence, accountability between visits	Essential, and the most underrated role
Phlebotomist / clinical staff	Frequent blood draws	Scale-dependent
Exercise physiologist	VO2 max testing, individualized exercise prescription	Add with scale
Registered dietitian	Nutrition protocols matched to member biology	Add with scale
Front office / member experience	Premium concierge experience	Model-dependent

The medical director or lead physician sets clinical vision, oversees protocols, and signs off on care plans, usually from a preventive, functional, or internal medicine background. The nurse practitioner or physician assistant manages member follow-ups and runs day-to-day clinical operations. A phlebotomist or clinical staff handle the frequent blood draws that are part of the workflow, while the exercise physiologist runs VO2 max testing and prescribes exercise, and the registered dietitian builds nutritional protocols matched to member biology.

The health coach is the most underrated role on the list and the most critical. The health coach translates clinical protocols into daily behavior, manages adherence between physician visits, and provides the accountability layer that determines whether protocols actually produce outcomes. Finally, front office and member experience handle the premium patient experience that is part of the value proposition for cash-based concierge models.

In year one, a lean team of physician, nurse practitioner, health coach, and admin can run a 100 to 200 member practice, and specialization comes with scale. The health coach role frequently gets cut early under budget pressure, which is exactly the wrong move, because it is the role that determines whether the protocols actually get followed.

Compliance, legal, and the architecture of trust

The compliance non-negotiables follow, with the disclaimer that this is informational and not legal advice. Consult counsel for the relevant jurisdiction.

Entity structure is a Professional Corporation or Limited Liability Company, with state-specific medical-ownership requirements determining which form applies.
Medical licensure must cover all clinical staff for the state of operation, and telehealth crosses state lines with regulatory complexity that varies by state.
HIPAA compliance requires Business Associate Agreements with every vendor handling protected health information, and an audit trail is mandatory.
Medical malpractice insurance must extend to off-label and novel therapies if offered, with specialized riders for peptides, hormone therapy, and regenerative therapies.
Marketing compliance means claims must be substantiated, FTC guidelines on health claims apply, and words like “cure,” “guarantee,” and “reverse aging” are red flags.
State-specific considerations include corporate-practice-of-medicine doctrines and rules for hormone therapy and peptide prescribing, which vary across states.
For international operations, GDPR applies if EU members are involved, alongside data residency requirements and cross-border telehealth nuances that are still evolving.

Compliance investment in year one prevents expensive remediation in year three, and the clinics that get this right are also the clinics that investors fund.

The economics, membership models, and unit economics

Three revenue structures cover most current longevity practice. Membership or concierge models provide predictable recurring revenue through tiered structures (basic, premium, family). A-la-carte program packages are often built around a diagnostic-and-protocol bundle such as a six-month metabolic reset. And most practice is cash-based rather than insurance-billing, because the services are not insurance-reimbursable, though some diagnostic tests may be partially covered.

Unit economics are driven by Member Lifetime Value, which depends on annual membership revenue, renewal rate, and per-member service uptake. Customer Acquisition Cost then determines profitability, and an LTV-to-CAC ratio above 3 to 1 is the operator target.

The renewal-rate lever is where most operators underinvest. What drives renewal is perceived value, and what drives perceived value is measured outcomes and sustained engagement. This loops back to workflow architecture, because the operational design that drives outcomes is also the lever that drives unit economics. In year one, focus on member depth (high retention, deep service uptake) rather than member breadth, since the growth playbook reverses by year three.

For deeper coverage of membership models that work, see Reya’s piece on longevity clinic membership models [internal link to be inserted when published].

Patient acquisition for the right members

The right member profile for a longevity practice is health-conscious, financially able to invest in proactive care, and motivated to participate, which is the Participatory P of the framework.

Three acquisition channels consistently work.

Referrals from primary care, cardiology, and endocrinology carry the highest LTV.
Targeted digital marketing built around SEO for healthspan, longevity, and biological age content, plus LinkedIn outreach for executive segments, reaches the right buyer.
And educational events and partnerships with physician practices, executive wellness programs, and corporate health programs build a credentialed pipeline.

The channels that look attractive but underperform are broad social-media advertising, influencer partnerships, and generic Google ads, where CAC runs high and the wrong members enroll and churn quickly. Wrong-member acquisition is more expensive than no acquisition, because CAC is recoverable while member-fit mismatch is not.

The honest critique, what most longevity clinics get wrong

Marc Demaria’s 2025 editorial in Aging-US (“Longevity clinics: between promise and peril”) deserves serious engagement. The editorial argues that many longevity clinics operate outside conventional medical systems, lack academic geroscience connections, and market expensive interventions without sufficient clinical validation.

The critique is partially fair, because two patterns get the field a bad reputation. The first is the wellness retreat with biomarkers, which offers high cost and a low evidence base, a premium experience without measurable outcomes. The second is the single-modality clinic in longevity clothing, meaning TRT shops, IV drips, and peptide-only practices using the longevity label without delivering multi-pillar care.

The legitimate longevity clinics are the ones that apply the 4P framework rigorously, cite peer-reviewed evidence for their protocols, measure outcomes (biomarkers, biological age, functional measures, member-reported health), stay transparent about what is evidence-supported versus experimental, and stay engaged with the academic geroscience field. Founders entering the space in 2026 have an advantage, because the legitimacy bar has risen, and the clinics that take the critique seriously are the ones that build durable practices.

The Road Ahead for Longevity Clinics

Opening a longevity clinic in 2026 is one of the most operationally interesting bets in healthcare. The clinical framework is clear, the diagnostic toolkit is broadening, and member demand is documented. The German market alone is projected to grow at 8.4 percent annually through 2030.

The founders who execute well are the ones who solve the workflow architecture problem early, through continuous engagement, integrated data, behavior-change support, and multidisciplinary care. Those are what separate a working practice from a marketing exercise.

The operating system that layers onto your existing stack. Reya is the longevity-intelligence layer built for longevity clinics, and it sits on top of your existing EMR/EHR rather than replacing it. It is designed around the 4P framework, with AI agents handling member intake, biomarker monitoring through the Wearables Monitor (Oura, Whoop, Apple Health), behavior-change coaching, and continuous care coordination, all condensed into the Northstar view across the 6 Pillars. The customer base spans new founders launching their first clinic to multi-site practices scaling across countries. If you are starting a longevity clinic in 2026, the intelligence layer you build on is one of the few year-one decisions that compounds for the entire life of the practice.

Book a demo →

Frequently Asked Questions

1) How much does it cost to start a longevity clinic?

Costs vary sharply by delivery model. Telehealth-first launches are the leanest path. Independent in-person or hybrid setups run roughly $107,000 to $130,000 for consulting, clinical protocol setup, technology, staffing, and initial marketing, per Altos Consulting Group’s 2026 estimate, with build-out and diagnostic equipment additional. Franchise models require $250,000 to $650,000 in liquid capital upfront. Diagnostic equipment such as DEXA and VO2 max systems ranges from $20,000 to $80,000 per unit and is the largest single capital line for in-person clinics.

2) Do longevity clinics need to be in-person or can they be fully telehealth?

Both models exist. Telehealth-first launches faster and cheaper, with national scalability, but the trade-off is reduced clinical depth and weaker patient rapport, which often shows up as higher churn. In-person clinics deliver higher per-member depth and stronger unit economics but require capital for build-out and diagnostic equipment. Hybrid models are increasingly the modal choice and the hardest to execute well in year one.

3) How long does it take to launch a longevity clinic?

Telehealth-first clinics can launch in 4 to 8 weeks. Independent in-person or hybrid clinics typically take 4 to 6 months from planning to opening, depending on build-out and equipment lead times. Altos Consulting Group targets a 60-day launch window for their engagement model. Compliance setup, vendor contracting, and clinical protocol development are the rate-limiting steps in most cases.

4) What credentials do I need to open a longevity clinic?

The medical director typically holds an MD or DO with a background in preventive medicine, internal medicine, family medicine, or functional medicine. Board certification in age management or anti-aging medicine, such as A4M, is common but not required. Each clinical staff member must be licensed for the state of operation, and corporate-practice-of-medicine rules vary by state and shape entity structure.

5) What is the minimum diagnostic equipment a longevity clinic needs?

The functional minimum includes blood draw capability (in-house or partner lab), DEXA scan access, VO2 max testing capability, and biological age testing via partner labs. Whole-body MRI, IV therapy infrastructure, and additional specialty equipment are common but not required at launch. Many year-one clinics partner for imaging rather than owning it.

6) What are the most common reasons new longevity clinics fail?

Three patterns dominate. Workflow architecture failure, where the clinic delivers quarterly snapshots rather than continuous care and members churn within the first year. Member-fit mismatch, where high CAC acquires members who do not match the practice model. And undercapitalization of the operational layer, where founders invest in clinical credentials and diagnostic equipment but underinvest in the software and health-coach roles that determine whether protocols actually produce outcomes.